Stem Cells From Human Exfoliated Teeth in Treatment of Type 2 Diabetes

Status Completed

Clinical Trial Summary

To evaluate the safety and efficacy of Stem Cells From Human Exfoliated Teethtransplantation in patients with type 2 diabetes to provides scientific basis for further clinical studies to verify the safety and efficacy of type 2 diabetes.On the basis of maintaining the original treatment, intravenous drip of Stem Cells From Human Exfoliated Teeth.

Clinical Trial Description

Basic treatment:

The original treatment regimen was maintained. During the study period, insulin dose could be adjusted with the change of blood glucose, while the type and dose of oral hypoglycemic drugs remained unchanged (except when side effects of drugs or insulin preparations were stopped or patients still had frequent hypoglycemia).

Stem cell therapy:

Dosage: Stem Cells From Human Exfoliated Teeth were calculated at 0.1IU/kg body weight .

Course of treatment: 3 times, respectively at the time of enrollment, 1 week after enrollment and 4 weeks after enrollment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03658655
Study type	Interventional
Source	CAR-T (Shanghai) Biotechnology Co., Ltd.
Contact
Status	Completed
Phase	Early Phase 1
Start date	June 1, 2018
Completion date	November 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03239366` - A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population	Phase 2
Completed	`NCT04597229` - Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus	N/A
Completed	`NCT03623139` - Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes	N/A
Active, not recruiting	`NCT04599920` - Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life)	N/A
Active, not recruiting	`NCT03422471` - Hypoglycemia and Autonomic Nervous System Function- B2	N/A
Completed	`NCT04382521` - A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions	N/A
Recruiting	`NCT04564391` - Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins	N/A
Recruiting	`NCT03458715` - The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin	Phase 4
Terminated	`NCT03278236` - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?	N/A
Completed	`NCT02974504` - Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)	Phase 4
Completed	`NCT05053828` - Type 2 Diabetes With Antiplatelet Drugs
Not yet recruiting	`NCT03659383` - The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine	Phase 4
Completed	`NCT03542240` - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome	N/A
Completed	`NCT03657537` - Effects of Ketone Bodies on Cognition in Type 2 Diabetes	Phase 1
Completed	`NCT03979768` - Risk Assessment of Type 2 Diabetes in Pharmacies	N/A
Completed	`NCT03614039` - Effect of Probiotic and Smectite Gel on NAFLD	N/A
Active, not recruiting	`NCT04994288` - A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients	Phase 2/Phase 3
Completed	`NCT03290768` - Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)	N/A
Enrolling by invitation	`NCT04088851` - "The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"	N/A
Completed	`NCT03643783` - Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients